SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-004647
Filing Date
2020-04-29
Accepted
2020-04-29 16:30:40
Documents
4
Period of Report
2020-06-18
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tgtx-20200618xdef14a.htm DEF 14A 797491
2 GRAPHIC tgtx-20200618xdef14ag001.jpg GRAPHIC 11322
3 GRAPHIC tgtx-20200618xdef14ag002.gif GRAPHIC 100993
4 GRAPHIC tgtx-20200618xdef14ag003.gif GRAPHIC 38544
  Complete submission text file 0001558370-20-004647.txt   1006944
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 20830801
SIC: 2834 Pharmaceutical Preparations